RxDoctor Payments Data

Kasey Khan

Psychiatric/Mental Health · Marion, ILNPI 1093206856

Payments from drug & device makers

$4,889in general payments, 2019–2025

Across 298 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$821
  • Neurocrine Biosciences, Inc.$576
  • Vanda Pharmaceuticals Inc.$569
  • Johnson & Johnson$466
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$448
  • Otsuka America Pharmaceutical, Inc.$429
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$4,81498%
  • Education$742%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,889 in reported general payments places this provider in the 90th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$860
Medicare patients
12
Services billed
12

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate15$119,111
Invega SustennaPaliperidone Palmitate30$89,842
RexultiBrexpiprazole44$69,088
VraylarCariprazine Hcl34$48,815
AristadaAripiprazole Lauroxil12$36,632
TrintellixVortioxetine Hydrobromide57$36,599
Aripiprazole182$14,168
Lurasidone Hcl68$12,517
Paliperidone ErPaliperidone52$12,430
BelsomraSuvorexant26$11,544
Alprazolam680$6,180
Desvenlafaxine Succinate ErDesvenlafaxine Succinate62$4,325
Eszopiclone51$4,315
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine143$3,807
Vilazodone Hcl33$3,364

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$576$119,11115 claims
Johnson & JohnsonInvega Sustenna$466$89,84230 claims
Otsuka America Pharmaceutical, Inc.Rexulti$429$69,08844 claims
AbbVieVraylar$821$48,81534 claims
Alkermes, Inc.Aristada$350$36,63212 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$252$36,59957 claims
Almatica Pharma LLCSertraline Hcl$31$1,104230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Marion

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →